These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9139528)

  • 21. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
    Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
    Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
    Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
    Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
    Grigor'ev ME; Mazo EB; Chekhonin VP
    Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
    Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
    Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
    Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies.
    Boddy JL; Dev S; Pike DJ; Malone PR
    BJU Int; 2004 Apr; 93(6):735-8. PubMed ID: 15049982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
    Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
    Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
    Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ
    Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness of prostate specific antigen density as a screening method for prostatic carcinoma.
    Chakrabarti S; Raha K; Bhunia CL; Bhattachary DK
    J Indian Med Assoc; 2001 Nov; 99(11):627-8, 630. PubMed ID: 12022203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship of PSA to age and prostatic volume in patients with benign prostatic hypertrophy].
    Sánchez Sánchez E; Paez Borda A; Herrero Payo A; Ruiz Rubio JL; Acebal Lucía J; Berenguer Sánchez A
    Actas Urol Esp; 1995 Mar; 19(3):181-6. PubMed ID: 8659273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White blood cell count is positively associated with benign prostatic hyperplasia.
    Fujita K; Hosomi M; Nakagawa M; Tanigawa G; Imamura R; Uemura M; Nakai Y; Takayama H; Yamaguchi S; Nonomura N
    Int J Urol; 2014 Mar; 21(3):308-12. PubMed ID: 23980666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health characteristics and sedentary behavior impact on prostate-specific antigen levels in a national U.S. sample.
    Loprinzi PD; Kohli M
    J Phys Act Health; 2014 Nov; 11(8):1587-92. PubMed ID: 24384552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can bicycling affect my PSA level?
    Health After 50 Sci Am Consum Health; 2015 Dec; 27(12):7. PubMed ID: 27062746
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma zinc level estimation in enlarged prostate.
    Bandlish U; Prabhakar BR; Wadehra PL
    Indian J Pathol Microbiol; 1988 Jul; 31(3):231-4. PubMed ID: 2466785
    [No Abstract]   [Full Text] [Related]  

  • 39. [ABO blood groups in hypertrophy of the prostate].
    PROSSER I
    Minerva Urol; 1959; 11():253-5. PubMed ID: 14435095
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis of fatality in hypertrophy of the prostate].
    VOROBTSOV VI
    Khirurgiia (Mosk); 1954 Feb; 2():60-4. PubMed ID: 13152939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.